Why the study?
While TAVR is proven safe and effective in high- and intermediate-risk aortic stenosis, data on its safety and efficacy in low-surgical-risk patients remain limited.
Does transcatheter aortic-valve replacement improve clinical outcomes compared to surgical aortic valve replacement in low-surgical-risk patients?
Population
6,293 low-surgical-risk patients across seven studies
Comparison
TAVR vs SAVR
Design
Meta-analysis
Follow-up
1-year
Authors
Loading...
Supports TAVR as alternative to SAVR in low-risk patients; confirms comparable 1-year mortality and stroke with lower atrial fibrillation.
Does transcatheter aortic-valve replacement improve clinical outcomes compared to surgical aortic valve replacement in low-surgical-risk patients?
In low-surgical-risk patients, TAVR demonstrates similar 1-year mortality and stroke rates compared to SAVR, with less atrial fibrillation but potentially more paravalvular leak.
Goel et al. (2019) studied this question.